To functionally assess if targeting the MR-IE of CCA reinstates immune recognition and the elimination of cancer cells, we used CAR-T cells as a model for cancer cell-targeted, immune cell-induced cytotoxicity. This evidence concerns the gene NR3C2 and cholangiocarcinoma.